<DOC>
	<DOCNO>NCT00463762</DOCNO>
	<brief_summary>The primary objective collect data treatment outcome ( clinical microbiological cure ) , safety tolerability treatment cefoperazone/sulbactam patient serious intra-abdominal hepatobiliary infection Slovakia .</brief_summary>
	<brief_title>Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections .</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Wound Infection</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Abdominal Abscess</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Cefoperazone</mesh_term>
	<mesh_term>Sulperazone</mesh_term>
	<criteria>Male female patient age 18 year old . Patient intraabdominal/hepatobiliary infection. ? Patients know hypersensitivity penicillin , cephalosporin , cefoperazone sulbactam .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>